ESC 365 - Empagliflozin versus dapagliflozin in heart failure

ESC2025 Premium Access

Empagliflozin versus dapagliflozin in heart failure

Session: Heart failure therapy across the spectrum

Topic: Pharmacotherapy

Speaker: Mr K. Bonnesen (Copenhagen, DK)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Mr Kasper Bonnesen

Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen (Denmark)

0 follower

7 more presentations in this session

Comparative effectiveness of tirzepatide as an add-on to SGLT2i versus SGLT2i monotherapy in HFpEF: a multi-institutional propensity score-matched study

Speaker: Doctor Y. Lin (Tainan, TW)

Early diagnosis of Wild-type Transthyretin Amyloidosis Cardiomyopathy by optimized screening of patients undergoing Carpal Tunnel Syndrome Surgery (CACTuS II)

Speaker: Mrs S. Fensman (Aarhus N, DK)

Effects of sodium-glucose co-transporter-2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis

Speaker: Doctor R. Cordovez (Cebu City, PH)

Home-based rehabilitation in patients with chronic heart failure after acute decompensation: primary results of the PILOT-CRHF trial

Speaker: Doctor A. Reuser (Leipzig, DE)

Efficacy of early angiotensin receptor/neprilysin inhibition in post-myocardial infarction patients: a meta-analysis of randomized controlled trials

Speaker: Associate Professor C. Hsu (Taipei, TW)

Access the full session

Heart failure therapy across the spectrum

Speakers: Mr K. Bonnesen, Doctor Y. Lin, Mrs S. Fensman, Doctor R. Cordovez, Doctor A. Reuser...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources